AI-guided design of common light chains to enable manufacturable bispecific antibodies
Greisen, P.; Garces, F.; French, J. B.; Zhou, Y.; Richardson, B. M.; Cong, L.; Pang, Z.; Lang, Y.; Li, T.; Shek, R.
Show abstract
Bispecific antibodies (BsAbs) offer therapeutic advantages but face manufacturing bottlenecks from light chain mispairing, which can generate a substantial fraction of incorrect products and increase manufacturing complexity and cost of goods. Common light chains (cLC) eliminate mispairing, yet existing approaches require screening thousands of variants per target. We present an AI-driven framework that computationally designs cLCs through structure-guided pairing of non-cognate VH-VL interfaces, reducing experimental screening by three orders of magnitude. The platform successfully engineers therapeutic antibodies lacking experimental structures, expanding applicability beyond crystallographic databases. Among 10 therapeutic targets, we successfully generated designs for 7 targets, comprising 55 unique BsAb pairs. Of these, 43.6% (24/55) were successfully as BsAb cLCs. Three bispecific antibodies reached production-ready specifications: >90% purity and 1.6-1.8 g/L titers. This platform democratizes bispecific antibody development, expanding access beyond well-resourced programs.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Engineering of highly active and diverse nuclease enzymes by combining machine learning and ultra-high-throughput screening 95%
- AlphaFold2 enables accurate deorphanization of ligands to single-pass receptors 94%
- FlowDesign: Improved Design of Antibody CDRs Through Flow Matching and Better Prior Distributions 93%
Similar papers in this journal
Similar papers in this journal
- Direct prediction of intrinsically disordered protein conformational properties from sequence 94%
- Sliding Window INteraction Grammar (SWING): a generalized interaction language model for peptide and protein interactions 94%
- Megabodies expand the nanobody toolkit for protein structure determination by single-particle cryo-EM 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.